Muscular Dystrophy Clinical Trials

A listing of Muscular Dystrophy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
featured
Memory Education and Research Initiative (MERI)

The MERI program began in 2003 under the direction of Nunzio Pomara, MD and was developed  to offer memory and cognitive evaluations to members of the community at no cost. This

  • 0 views
  • 23 Jul, 2021
  • 1 location
Targeted Multidomain (T-MD) Interventions for Complex Mild Traumatic Brain Injury (mTBI)

Objective: This 3-year multisite RCT will determine the effectiveness of a targeted multidomain intervention (T-MD) (anxiety/mood, cognitive, migraine, ocular, vestibular; and sleep, autonomic

  • 0 views
  • 20 Jul, 2021
  • 2 locations
Minimally Invasive Vestibular Neurectomy Versus Tenotomy of the Stapedius and Tensor Tympani Muscles in the Management of Patients With Unilateral Meniere's Disease

The distinctive symptoms of Meniere's disease (MD) include recurrent vertigo spells, fluctuating hearing loss, aural fullness and tinnitus. Conservative treatment in MD comprises lifestyle

  • 0 views
  • 18 Jul, 2021
  • 1 location
A Single-dose Open-label Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

This study will assess the pharmacokinetics of belapectin in subjects with mild, moderate, or severe hepatic impairment according to 3 different Child-Pugh categories: mild, moderate, or severe impairment, compared to matched healthy control subjects.

direct bilirubin
drug tests
prothrombin
liver disease
electrocardiogram
  • 0 views
  • 17 Jul, 2021
  • 4 locations
Study of Safety Tolerability and Pharmacokinetics of INE963 in Healthy Participants

multiple dose (MD) study with 1 planned cohort of 9 participantsEligible participants will be randomized to receive either a single dose or a dose q24h x 3 day of either INE963 or placebo depending on

  • 0 views
  • 01 Aug, 2021
  • 1 location
Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy

This trial is designed to assess the efficacy of a novel carbon-fibre adjustable reusable accessory (CARA) for breast support to reduce skin toxicity and unwanted normal tissue dose in comparison to the current clinical standard for supine breast support during whole breast RT.

  • 0 views
  • 26 Jul, 2021
  • 1 location
A Phase 3 Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)

To evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids administered every two weeks in ambulatory subjects with Duchenne muscular

duchenne muscular dystrophy
corticosteroids
calcium
prednisolone
serum electrolyte
  • 0 views
  • 29 Jul, 2021
  • 49 locations
A Phase 3 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy

The study will evaluate the safety and efficacy of gene therapy in boys with DMD. It is a randomized, double-blind, placebo-controlled study with two thirds of participants assigned to gene therapy. The one third of participants who are randomized to the placebo arm will have an opportunity for treatment with …

duchenne muscular dystrophy
gene therapy
prednisolone
  • 0 views
  • 01 Aug, 2021
  • 26 locations
A Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)

To evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids in subjects with non-ambulatory Duchenne muscular dystrophy (age 12 years and older

prednisone
pneumococcal vaccine
corticosteroids
electrolytes
deflazacort
  • 60 views
  • 01 Aug, 2021
  • 53 locations
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy

This is a randomized, multicenter, double-blind, placebo-controlled, Phase 2/3 study of patients (aged 6 to 16 years) diagnosed with Congenital Myotonic Dystrophy (Congenital DM1).

weakness
myotonic dystrophy
  • 0 views
  • 01 Aug, 2021
  • 13 locations